Dementia with Lewy bodies: Reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease

Neuropathology

Volumn 24, Issue 1, 2004, Pages 72-78

  Iseki, Eizo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

synuclein; Alzheimer pathology; Dementia with Lewy bodies; Lewy pathology; Pathological subtypes

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ALZHEIMER DISEASE; AUTOPSY; BRAIN CORTEX; CELL LOSS; CONFERENCE PAPER; DEMENTIA; DIENCEPHALON; ENTORHINAL CORTEX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; HUMANS; LEWY BODY DISEASE; MIDDLE AGED; PARKINSON DISEASE;

EID: 1642283254     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2003.00530.x     Document Type: Conference Paper

References (21)

1. McKeith IG, Glasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB workshop. Neurology 1996; 47: 1113-1124.
2. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197-204.
3. Kosaka K. Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol (Berl) 1978; 42: 127-134.
4. Leigh PN, Probst A, Dale GE et al. New aspect of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (Berl) 1989; 79: 61-72.
5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-Synuclein in Lewy bodies. Nature 1997; 388: 839-840.
6. Baba M, Nakajo S, Tu PH et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879-884.
7. Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K. Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 1999; 19: 386-394.
8. Marui W, Iseki E, Nakai T et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002; 195: 153-159.
9. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
10. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol, 1999; 56: 33-39.
11. Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standarization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
12. Marui W, Iseki E, Ueda K, Kosaka K. Occurrence of human α-synuclein-immunoreactive neurons with neurofibrillary tangle formation in the limbic areas with Alzheimer's disease. J Neurol Sci 2000; 174: 81-84.
13. Katsuse O, Iseki E, Marui W, Kosaka K. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci, 2003; 211: 29-35.
14. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
15. Kosaka K, Iseki E, Odawara T, Yamamoto T. Cerebral type of Lewy body disease. Neuropathology 1996; 16: 32-35.
16. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990; 95: 119-139.
17. Hansen LA, Salmon D, Galasko D et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1-8.
18. Lippa CF, Fujiwara H, Mann DM et al. Lewy bodies contain alteredα-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153: 1365-1370.
19. Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y. α-Synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Brain Res 2001; 888: 287-296.
20. Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, Iwatsubo T. Degenerative terminals of the perforant pathway are human α-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 1998; 258: 81-84.
21. Iseki E, Marui W, Kosaka K, Ueda K. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 1999; 265: 9-12.